IMPORTANT NOTICE

Coronavirus (COVID-19) and the Driver Testing Service

Under Covid19 Level 5 Government restrictions effective from midnight on Wednesday 21 October, for six weeks, you can attend your scheduled driving test appointment provided you are an essential worker involved in the provision of essential services or essential retail outlets. You can view the list of essential services at Level 5 on www.gov.ie 

Cancelling your Test

If you are not involved in the provision of essential services or essential retail outlets, please cancel you test appointment here.

Waiting for a Test Date?

We are experiencing a high demand for driving tests at the moment. If you have submitted a driving test application we will be in touch with an appointment date, there is no need to contact us.

Need a test urgently?

If you are an essential worker and require an urgent test in connection with that work, then you can request a test here.  

Drug Driving: prevalence, risks and detection

The Road Safety Authority (RSA) held their 10th Annual Academic Lecture on Monday 7 October 2019 in the Royal College of Surgeons, Dublin.

The lecture focused on Drug Impaired Driving and featured insights on the subject from international and national experts.

This included Professor Denis A. Cusack, Director, Medical Bureau of Road Safety who discussed drug impaired driving in Ireland; Dr Vigdis Vindenes, Head of Research, Dep. of Forensic Sciences, Oslo University Hospital who presented on impairment based legislative limits which have been imposed in Norway; and Assistant Commissioner, David Sheahan of An Garda Síochána, who discussed enforcement of drug driving in Ireland.


Figures unveiled at the Annual Academic Lecture, show that drug driving is a major problem on Ireland’s roads. They show that 68% of drivers with a positive roadside drug test, between April 2017 and July 2019, had a positive test for cannabis. Cocaine follows closely behind as the main illicit drug detected after cannabis, with 37% of samples tested being positive for cocaine. The Medical Bureau of Road Safety (MBRS) findings also demonstrate that cannabis is now not far behind alcohol in blood and urine samples it examined.


The Academic Lecture also unveiled preliminary results from a collaboration between the RSA, Health Research Board (HRB) and MBRS, looking at the presence of drugs amongst road user fatalities. Analyses of the toxicology results of 310 driver and motorcyclists killed during 2013-2016 demonstrated that:

• 11% had a positive toxicology for at least one benzodiazepine
• 8% had a positive toxicology for cocaine
• 7% had a positive toxicology for cannabis

For driver fatalities with a positive toxicology for at least one of the drug categories examined in the study (n = 90), 86% were male, and just over half were aged 25-44 years*. 

Recordings of the presentations will be available shortly.

This page has been optimized for IE7 & IE8. Should you experience difficulty in using any of the controls on this page, you may need to upgrade your browser version.

TV Ads